Study type

Study topic

Human medicinal product
Disease /health condition

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness

Data collection methods

Secondary data collection
Non-interventional study

Non-interventional study design

Systematic review and meta-analysis
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(C03AA) Thiazides, plain

Medical condition to be studied

Skin cancer
Skin cancer metastatic
Population studied

Short description of the study population

Subjects with non-melanoma skin cancer (NMSC) and malignant melanoma (MM) identified from the interventional and non-interventional studies received treatment with any thiazide diuretic, single or in combination, at class level or substance level.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Malignant melanoma patients

Estimated number of subjects

100000
Study design details

Main study objective

To quantify the association between the use of thiazides drugs and the risk of skin cancer

Outcomes

Skin cancer

Data analysis plan

A search in Medline and Embase was conducted in order to identify interventional and non-interventional studies that investigated the association between thiazides and NMSC or MM in any population
Documents